Overview

Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection

Status:
Withdrawn

Trial end date:
2013-05-01

Target enrollment:

Participant gender:

Summary

To evaluate the efficacy and safety of fixed combination of azithromycin 1.5% + 0.5% Loteprednol eye drops for the treatment of ocular inflammation and infection associated bacterial blepharitis and / or keratitis and / or conjunctivitis compared with the individual administration of azithromycin 1.5% and 0.5% Loteprednol (separately).

Phase:

Phase 3

Details

Lead Sponsor:

Adapt Produtos Oftalmológicos Ltda.

Treatments:

Azithromycin
Loteprednol Etabonate
Ophthalmic Solutions
Tetrahydrozoline